Clinical trial
Study on the Relationship Between Opioid Drugs and the Therapeutic Efficacy of Immunotherapy
NCT07188857 is registered in ClinicalTrials.gov with Hubei Cancer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Relationship Between Opioid Drugs and the Therapeutic Efficacy of Immunotherapy
- Lead sponsor
- Hubei Cancer Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 17, 2025
- Completion date
- October 1, 2027
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
immune checkpoint inhibitor, opioid, pain management